NEO Proteomics
Biotechnology ResearchOhio, United States2-10 Employees
NEO Proteomics operates in the biotechnology research sector, offering protein structure characterization services to both industry and academic laboratories. Its work centers on protein footprinting and related biophysical techniques, providing researchers with detailed insights into protein structure on a per-project basis. Based in Cleveland, Ohio, the company benefits from a team led by Chief Scientific Officer and Co-Founder Dr. Mark Chance, who has helped advance covalent labeling by mass spectrometry, a foundational method for protein characterization. The customer base comprises research organizations seeking fast, high-resolution structural information to inform experiments and discovery, with NEO Proteomics positioned as a specialized service provider focused on advancing protein structure interrogation. A notable recent development is a collaboration with GenNext Technologies to support a seminar series on protein footprinting, illustrating active engagement with partners to expand knowledge around its core capabilities.